Integer Holdings (ITGR) Non-Current Deferred Tax Liability (2010 - 2026)

Integer Holdings (ITGR) reported Non-Current Deferred Tax Liability of $115.1 million for Q2 2026, up 3.51% on a YoY basis from $111.2 million in Q2 2025, and down 1.06% sequentially from $116.3 million in Q4 2025.

Integer Holdings (ITGR) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends

Integer Holdings (ITGR) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $115.1 million in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Deferred Tax Liability rose 3.51% year-over-year to $115.1 million; the trailing twelve-month figure through Apr 2026 stood at $115.1 million (up 3.51% YoY), and the FY2025 full-year result was $116.3 million, down 43.69% from the prior year.
  • Non-Current Deferred Tax Liability declined to $115.1 million in Q2 2026, from $116.3 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $206.6 million in Q4 2024 to a low of $111.2 million in Q1 2025.
  • A 5-year average of $147.0 million and a median of $145.2 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability jumped 43.92% in 2024 and slumped 43.69% in 2025, its largest moves.
  • Tracing ITGR's Non-Current Deferred Tax Liability over 5 years: stood at $160.7 million in 2022, then retreated by 10.65% to $143.6 million in 2023, then jumped by 43.92% to $206.6 million in 2024, then tumbled by 43.69% to $116.3 million in 2025, then dropped by 1.06% to $115.1 million in 2026.
  • Business Quant data shows ITGR's Non-Current Deferred Tax Liability at $115.1 million in Q2 2026, $116.3 million in Q4 2025, and $114.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Integer Holdings 3.34 Bn 3.33 Bn 109.60 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 115.10 Mn
Apr 3, 2026 115.10 Mn
Dec 31, 2025 116.33 Mn
Dec 31, 2025 116.33 Mn
Sep 26, 2025 114.70 Mn
Sep 26, 2025 114.70 Mn
Jun 27, 2025 114.74 Mn
Jun 27, 2025 114.74 Mn
Mar 28, 2025 111.20 Mn
Mar 28, 2025 111.20 Mn
Dec 31, 2024 206.60 Mn
Dec 31, 2024 206.60 Mn
Sep 27, 2024 143.24 Mn
Sep 27, 2024 143.24 Mn
Jun 28, 2024 144.10 Mn
Jun 28, 2024 144.10 Mn
Mar 29, 2024 145.20 Mn
Mar 29, 2024 145.20 Mn
Dec 31, 2023 143.55 Mn
Dec 31, 2023 143.55 Mn